Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| AZTA | NASDAQ | Azenta, Inc. | $37.17 | +1.84% | 658K | $1.63B |
| ABSI | NASDAQ | Absci Corporation | $9.45 | +2.94% | 3.4M | $1.62B |
| CERT | NASDAQ | Certara, Inc. | $10.61 | +2.71% | 2.3M | $1.62B |
| IMCR | NASDAQ | Immunocore Holdings plc | $31.28 | +0.97% | 198K | $1.61B |
| MESO | NASDAQ | Mesoblast Limited | $12.39 | +0.90% | 107K | $1.61B |
| RARE | NASDAQ | Ultragenyx Pharmaceutical Inc. | $16.08 | +2.75% | 3M | $1.59B |
| GENB | NASDAQ | Generate Biomedicines, Inc. | $12.35 | -0.48% | 341K | $1.59B |
| PAHC | NASDAQ | Phibro Animal Health Corporation | $39.03 | +0.59% | 145K | $1.58B |
| NBTX | NASDAQ | Nanobiotix S.A. | $31.53 | +7.39% | 130K | $1.58B |
| NTLA | NASDAQ | Intellia Therapeutics, Inc. | $11.26 | +0.45% | 2.1M | $1.58B |
| TRAX | NASDAQ | First Tracks Biotherapeutics Inc | $43.48 | -1.29% | 592K | $1.55B |
| NVAX | NASDAQ | Novavax, Inc. | $9.40 | -3.09% | 4.9M | $1.55B |
| BRVE | NASDAQ | Braveheart Bio, Inc. | $21.87 | +2.01% | 101K | $1.55B |
| CMPS | NASDAQ | COMPASS Pathways plc | $11.05 | -1.16% | 1.5M | $1.53B |
| INVA | NASDAQ | Innoviva, Inc. | $21.05 | +1.89% | 569K | $1.52B |
| LYCA | NASDAQ | Lycia Therapeutics Inc. | $28.85 | -3.83% | 965K | $1.5B |
| QURE | NASDAQ | uniQure N.V. | $21.65 | -3.48% | 989K | $1.5B |
| PNTG | NASDAQ | The Pennant Group, Inc. | $42.57 | +1.65% | 401K | $1.49B |
| ANAB | NASDAQ | AnaptysBio, Inc. | $48.77 | +0.08% | 417K | $1.46B |
| PCRX | NASDAQ | Pacira BioSciences, Inc. | $36.38 | -0.11% | 607K | $1.45B |
| AAPG | NASDAQ | Ascentage Pharma Group International | $15.45 | +0.06% | 3K | $1.44B |
| ETON | NASDAQ | Eton Pharmaceuticals, Inc. | $50.17 | +0.34% | 399K | $1.43B |
| NUTX | NASDAQ | Nutex Health, Inc. | $209.01 | -0.28% | 197K | $1.43B |
| OCUL | NASDAQ | Ocular Therapeutix, Inc. | $6.47 | -0.46% | 1.7M | $1.42B |
| GHRS | NASDAQ | GH Research PLC | $19.18 | +6.14% | 306K | $1.32B |
| TNDM | NASDAQ | Tandem Diabetes Care, Inc. | $18.90 | +8.43% | 4.5M | $1.32B |
| DMRA | NASDAQ | Damora Therapeutics, Inc. | $21.26 | +0.81% | 642K | $1.31B |
| INBX | NASDAQ | Inhibrx Biosciences Inc. | $88.61 | -5.11% | 251K | $1.3B |
| TSHA | NASDAQ | Taysha Gene Therapies, Inc. | $4.01 | +1.26% | 1.7M | $1.3B |
| LBRX | NASDAQ | LB Pharmaceuticals Inc Common Stock | $39.34 | +1.58% | 276K | $1.27B |
| INNV | NASDAQ | Innovage Holding Corp. | $9.27 | -2.93% | 261K | $1.26B |
| CRON | NASDAQ | Cronos Group Inc. | $3.31 | -1.19% | 820K | $1.22B |
| TYRA | NASDAQ | Tyra Biosciences, Inc. | $20.42 | -0.15% | 790K | $1.22B |
| OPK | NASDAQ | OPKO Health, Inc. | $1.63 | +0.61% | 1.9M | $1.22B |
| RAPP | NASDAQ | Rapport Therapeutics, Inc. Common Stock | $25.33 | -2.31% | 1M | $1.22B |
| GPCR | NASDAQ | Structure Therapeutics Inc. | $21.10 | -0.42% | 686K | $1.21B |
| GDRX | NASDAQ | GoodRx Holdings, Inc. | $3.56 | +0.56% | 892K | $1.21B |
| AVLN | NASDAQ | Avalyn Pharma Inc. Common Stock | $27.14 | +4.22% | 411K | $1.2B |
| DRTS | NASDAQ | Alpha Tau Medical Ltd | $12.89 | -2.05% | 379K | $1.19B |
| SNDX | NASDAQ | Syndax Pharmaceuticals, Inc. | $13.22 | -1.34% | 2M | $1.18B |
| OMER | NASDAQ | Omeros Corporation | $16.29 | -1.69% | 741K | $1.18B |
| OMDA | NASDAQ | Omada Health | $19.24 | +1.53% | 870K | $1.18B |
| REPL | NASDAQ | Replimune Group, Inc. | $12.47 | +8.81% | 2M | $1.17B |
| STAA | NASDAQ | STAAR Surgical Company | $23.23 | +2.74% | 749K | $1.16B |
| PRCT | NASDAQ | PROCEPT BioRobotics Corporation | $19.83 | -0.65% | 702K | $1.13B |
| KARD | NASDAQ | Kardigan, Inc. | $12.63 | -1.33% | 216K | $1.13B |
| LMRI | NASDAQ | Lumexa Imaging Holdings, Inc. Common Stock | $11.74 | +0.69% | 310K | $1.13B |
| DRTSW | NASDAQ | Alpha Tau Medical Ltd. | $3.00 | -7.41% | 14K | $1.13B |
| BCAX | NASDAQ | Bicara Therapeutics Inc. Common Stock | $16.89 | -1.05% | 1.1M | $1.12B |
| SPTX | NASDAQ | Seaport Therapeutics, Inc. Common Stock | $20.83 | +1.07% | 125K | $1.12B |
50 Healthcare Companies
Review companies currently returned for the Healthcare screen, with price, performance, volume and market-cap context.
How This Sector Screen Works
Results are loaded from current company data and can be narrowed by exchange or company search without changing the canonical sector page.
About the Healthcare Sector
The Healthcare classification groups companies with related business activities so investors can compare peers within a common market segment.
Related Sector Screens
Return to the screener directory to compare this sector with daily movers and the other industry groups covered by Cashu Finance.